EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 39 filers reported holding EDGE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,127,000 | -12.7% | 333,737 | 0.0% | 0.37% | -28.2% |
| Q3 2017 | $3,581,000 | +132.7% | 333,737 | +122.5% | 0.51% | +95.8% |
| Q2 2017 | $1,539,000 | +12.6% | 150,000 | 0.0% | 0.26% | -2.2% |
| Q1 2017 | $1,367,000 | -27.1% | 150,000 | 0.0% | 0.27% | -43.8% |
| Q4 2016 | $1,875,000 | +20.0% | 150,000 | 0.0% | 0.48% | +87.0% |
| Q3 2016 | $1,562,000 | +3.0% | 150,000 | 0.0% | 0.25% | -35.5% |
| Q2 2016 | $1,517,000 | +10.5% | 150,000 | 0.0% | 0.39% | +32.2% |
| Q1 2016 | $1,373,000 | -29.2% | 150,000 | -3.2% | 0.30% | +4.9% |
| Q4 2015 | $1,938,000 | – | 155,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |